Navigation Links
R&D/Leverage Heightens Investment in Medical and Silicone Mold Manufacturing

LEE'S SUMMIT, Mo., Oct. 2 /PRNewswire/ -- R&D/Leverage's enhanced medical and silicone mold manufacturing capabilities - seamlessly integrated under one roof - continue to expand in anticipation of further industry acceleration, according to David Wescoat, the company's Vice President - Engineering.

According to Wescoat, the company's ongoing investment includes the addition of technical and engineering staff, new lean initiatives and quality-control protocols and world-class analysis and process development techniques. The result is a one-stop supplier capability that helps customers create the superior end-products for the world's healthcare and pharma professionals.

"Medical molds, such as those used in high-volume disposable products, are complex, high-cavitation items that require ultra-precise tolerances and uncompromising quality," said Wescoat. "R&D/Leverage, today, offers an unsurpassed suite of services that provide world-class mold manufacturing for this demanding industry.

"Also," he said, "when required we have the capability to assist our customers with processing and molding for short-run capacity issues that arise from time to time.

"R&D/Leverage's suite of mold manufacturing assets includes a diverse group of tool makers, mold designers and project and mechanical engineers - all with access to our validation molding labs, clean rooms and analysis services that mathematically model thermal characteristics, mold deformation and stress, mold-flow and more," Wescoat said.

In addition, the company also now offers mold building for liquid silicone products, where ultra-fine tolerances and the ultimate in flexibility and temperature range integrity are required.

"Our medical mold manufacturing and silicone capabilities represent a significant investment in time and resources," Wescoat said. "Here is an on-campus cross-functional mold manufacturing team structured to help customers - all with the power of the combined strength and experience that supports our ongoing industrial design and consumer and retail audits with Leverage. Along with our custom mold manufacturing in other markets, we are truly a full-service Integrated Solutions provider."


R&D, Integrated Solutions in Plastics, is recognized as one of the world's leading suppliers of tooling for the food, beverage, home, personal care and healthcare industries. With offices in the United States and in the United Kingdom, R&D is a full-service plastic product solutions company. From idea, to tooling, to manufacturing, the company's packaging solutions support the branded product. Services include full mold manufacturing for PET tooling, IBM tooling, injection molds and a full range of support functions that include sampling analysis, mold maintenance, contract molding and processing assistance.

Leverage, Integrated Industrial Design, is R&D's full service consumer packaging design component, located in a separate facility within the R&D campus. Leverage's four-pronged range of services includes upfront research (retail audits, trend and color study, ethnographic research, consumer brainstorming); concept development (story boards, feasibility studies, digital prototyping, graphic design and branding); validation (online design, model making); and implementation (prototype molds, mold sampling and low-volume production).

(Editor's note: for a phone, or in-person interview, contact Robert Schiavone, R&D/Leverage, 816/525-0353,, or visit the company online: )


    Robert Schiavone

This release was issued through eReleases(TM). For more information, visit

SOURCE R&D/Leverage

SOURCE R&D/Leverage
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Risky sexual behavior among male clients of Tijuana sex workers heightens risk of HIV transmission
2. Depression Heightens Sensitivity to Pain
3. Acai Berry Health Foods Heightens Consumer Awareness of the Purple Miracle Berry
4. Economic Slump Heightens Need for Provider Vigilance in Care of Chronically Ill
5. Initiating drinking at younger age heightens womens risk for alcohol dependence
6. Test for Life Marks World AIDS Day, Heightens Awareness of HIV/AIDS Testing in the U.S.
7. Metabolic syndrome heightens risk for development of uric-acid kidney stones
8. Gates Foundation Launches Campaign to Highlight Success of U.S. Global Health Investments
9. Micell Receives $15 Million Equity Investment
10. HHS Prevention and Wellness Initiative, Including Tobacco Control, Is Smart Investment in Americas Health
11. Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act
Post Your Comments:
(Date:11/26/2015)... ... 2015 , ... Somu Sivaramakrishnan announced today that he joined ... offers travelers, value and care based Travel Services, including exclusive pricing on a ... cabin upgrades and special amenities such as, shore excursions, discounted fares, travel gifts ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack ... trailer titles work with any font, giving users limitless opportunities to stylize and ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and public R&D ... Nairobi (UNON) for the opening of the 5th African Network for Drugs and ...
(Date:11/25/2015)... Cleveland, OH (PRWEB) , ... November 25, 2015 , ... ... dental implants in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced ... 5th this year in Cleveland, OH. , As the co-founders of Advanced Implant ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology: